Профиль компании
- Фондовый код
- IONS
- ISIN-код
- US4622221004
- Валюта
- US Dollar (USD)
- Дата IPO
- 1991-05-17

Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS) and acute pancreatitis; DAWNZERA for prophylaxis to prevent attacks of hereditary angioedema in adults; WAINUA for the trea...